Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.

Amgen reached a $74 million settlement of a lawsuit accusing the biotechnology company of ​waiting t

Andra AP fonden cut its holdings in Amgen Inc. (NASDAQ: AMGN) by 18.9% during the undefined quarter,

On July 20, 2026, we present a DCF analysis for Amgen Inc (AMGN), a company that has shown strong pr

Dimensional Fund Advisors LP lifted its position in shares of Amgen Inc. (NASDAQ: AMGN) by 2.3% duri

Boston Common Asset Management LLC reduced its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 10.4%

Decker Wealth Management LLC purchased a new stake in Amgen Inc. (NASDAQ: AMGN) in the first quarter

The FDA's approval of Merck (NYSE:MRK | MRK Price Prediction) enlicitide decanoate, marketed as Lipf

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combinati

Amgen (AMGN) closed the most recent trading day at $355.25, moving 1.44% from the previous trading s

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony Bi

Pfizer (NYSE: PFE | PFE Price Prediction) and Amgen (NASDAQ: AMGN) both reported Q1 2026 results thi

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the

Guggenheim analyst Vamil Divan maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price

On July 13, 2026, we present a detailed DCF analysis for Amgen Inc (AMGN), a company that has shown

CNBC's Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter.

Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers

Near-term headwinds could sink the stock, but there is more to the story.

On CNBC's Mad Dash segment on Monday, July 6, 2026, Jim Cramer made one of his most bullish biotech

Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 1.05% on an annualized bas

Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the

Amgen (AMGN) closed the most recent trading day at $366.44, moving 2.06% from the previous trading s

Broadcom's Apple deal and AMD's self-driving ambitions powered the Nasdaq higher on Monday while the

Amgen (AMGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the compa

Cantor Fitzgerald analyst Carter Gould reiterates Amgen (NASDAQ:AMGN) with a Neutral and maintain

Elizabeth Warren warns Trump's law pushed children off Medicaid and CHIP in many states, while a

A federal judge on Wednesday blocked Colorado ​from capping the price of Amgen's blockbuster arthrit

CNBC Final trades: Lebenthal picks Micron, Snipe chooses Palo Alto, Brown expects Apple's good s

Shares of Quantinuum slide after rallying since IPO. Analysts weigh in.

FDA approves Viridian Therapeutics' Lumvoa for thyroid eye disease. Immediate commercial launch

As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and s

Top analysts changed ratings on top names, including Sunrun, enGene Therapeutics, Camp4 Therapeutics

U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on

A sharp rotation gripped Wall Street at midday Thursday as blue-chip industrials and healthcare powe

Sen. Warren challenges Trump's 600% TrumpRx drug price claim using a glass of water.

It's a big week for the Dow Jones Industrial Average with 11 of the 30 components reporting earn

A member of Congress recently bought hundreds of thousands of dollars in stocks, marking her first t

Viridian shares fall after Amgen TEPEZZA Phase 3 data shows stronger efficacy, raising concerns over

According to a Bloomberg report, Trump may impose 100% tariffs on drugmakers without pricing deals,

Amgen Inc. (NASDAQ: AMGN) and GSK plc (NYSE: GSK) are reportedly set to announce their partnership w

Here's a look at this week's earnings calendar, featuring over 100 S&P 500 members.

Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more

Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investo

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as s